GlassScriptPhysician profile
Milledge Newton
NPI 1255369435
$5,316.53
in general payments reported to CMS, 2019-2025
20 companies · $825 in 2025
The $825 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2020: $990 · 2021: $322 · 2022: $425 · 2023: $481 · 2024: $1,137 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,861 · Consulting Fee: $525 · Education: $56.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,861.29 |
| Consulting Fee | $525.00 |
| Education | $56.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,119.68 | 2019-2025 | Tagrisso, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $845.87 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Regeneron Healthcare Solutions, INC. | $785.30 | 2019-2025 | Dupixent |
| Genzyme Corporation | $398.70 | 2020-2025 | |
| Sunovion Pharmaceuticals INC. | $266.30 | 2019-2020 | |
| Grifols USA, LLC | $202.07 | 2019-2024 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $168.22 | 2019-2021 | |
| Mylan Specialty L.P. | $120.43 | 2019-2020 | |
| Amgen INC. | $96.02 | 2022-2025 | Tezspire |
| Verona Pharma, INC. | $82.27 | 2025 | Ohtuvayre |
| Insmed, INC. | $47.30 | 2019-2020 | |
| Circassia INC. | $35.17 | 2019-2020 | |
| Philips North America LLC | $28.45 | 2020 | |
| United Therapeutics Corporation | $23.11 | 2021 | |
| Glaxosmithkline, LLC. | $21.40 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $21.25 | 2022 | |
| Jazz Pharmaceuticals INC. | $19.25 | 2019 | |
| Baxter Healthcare | $15.11 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Fisher & Paykel Healthcare INC | $12.57 | 2019 | |
| Inogen, INC. | $8.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milledge Newton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.